Positive effects of liraglutide as adjunct to insulin in type 1 diabetes: glycaemic control and safety in a randomised, double blind, placebo controlled crossover trial

被引：0
|
作者：
Heller, S. R. [1 ]
Korsatko, S. [2 ]
Gurban, J. [2 ]
Jensen, L. [3 ]
Christiansen, E. [3 ]
Kiyomi, F. [4 ]
Pieber, T. R. [2 ]
机构：
[1] Univ Sheffield, Sch Med, Sheffield S10 2TN, S Yorkshire, England
[2] Med Univ Graz, Graz, Austria
[3] Novo Nordisk AS, Soborg, Denmark
[4] Novo Nordisk Pharma Ltd, Tokyo, Japan
来源：
DIABETOLOGIA | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3
引用
收藏
页码：S7 / S8
页数：2
相关论文
共 50 条
  • [1] Liraglutide as Adjunct to Insulin in Type 1 Diabetes: Effects on Glycemic Control and Safety in a Randomized, Double-Blind, Crossover Trial
    Heller, Simon R.
    Korsatko, Stefan
    Gurban, Jamala
    Jensen, Lene
    Christiansen, Erik
    Kiyomi, Fumiaki
    Pieber, Thomas R.
    DIABETES, 2013, 62 : A258 - A259
  • [2] Treatment with liraglutide as adjunct to insulin in type 1 diabetes; effects on counter regulatory response to hypoglycaemia: a randomised, double blind, crossover trial
    Pieber, T. R.
    Deller, S.
    Brunner, M.
    Jensen, L.
    Christiansen, E.
    Kiyomi, F.
    Heller, S. R.
    DIABETOLOGIA, 2013, 56 : S404 - S405
  • [3] Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial
    Dejgaard, Thomas Fremming
    Frandsen, Christian Seerup
    Hansen, Tanja Stenbaek
    Almdal, Thomas
    Urhammer, Soren
    Pedersen-Bjergaard, Ulrik
    Jensen, Tonny
    Jensen, Andreas Kryger
    Holst, Jens Juul
    Tarnow, Lise
    Knop, Filip Krag
    Madsbad, Sten
    Andersen, Henrik Ullits
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (03): : 221 - 232
  • [4] Effects of Liraglutide as Adjunct to Insulin on Counter-Regulatory Hormone Responses to Hypoglycemia in Type 1 Diabetes: A Randomized, Double-Blind, Crossover Trial
    Pieber, Thomas
    Deller, Sigrid
    Brunner, Martina
    Jensen, Lene
    Christiansen, Erik
    Kiyomi, Fumiaki
    Heller, Simon
    DIABETES, 2013, 62 : A258 - A258
  • [5] Photopheresis at onset of type 1 diabetes: a randomised, double blind, placebo controlled trial
    Ludvigsson, J
    Samuelsson, U
    Ernerudh, J
    Johansson, C
    Stenhammar, L
    Berlin, G
    ARCHIVES OF DISEASE IN CHILDHOOD, 2001, 85 (02) : 149 - 154
  • [6] Efficacy and safety of liraglutide added to capped insulin treatment in type 1 diabetes, the ADJUNCT TWO™ randomised trial
    Hirsch, I. B.
    Ahren, B.
    Pieber, T.
    Mathieu, C.
    Gomez-Peralta, F.
    Hansen, T.
    Philotheou, A.
    Christiansen, E.
    Jensen, T. J.
    Birch, S.
    Buse, J.
    DIABETOLOGIA, 2016, 59 : S357 - S357
  • [7] Effects of semaglutide on beta cell function and glycaemic control in participants with type 2 diabetes: a randomised, double-blind, placebo-controlled trial
    Kapitza, Christoph
    Dahl, Kirsten
    Jacobsen, Jacob B.
    Axelsen, Mads B.
    Flint, Anne
    DIABETOLOGIA, 2017, 60 (08) : 1390 - 1399
  • [8] Effects of semaglutide on beta cell function and glycaemic control in participants with type 2 diabetes: a randomised, double-blind, placebo-controlled trial
    Christoph Kapitza
    Kirsten Dahl
    Jacob B. Jacobsen
    Mads B. Axelsen
    Anne Flint
    Diabetologia, 2017, 60 : 1390 - 1399
  • [9] Liraglutide accelerates colonic transit in people with type 1 diabetes and polyneuropathy: A randomised, double-blind, placebo-controlled trial
    Wegeberg, Anne-Marie Langmach
    Hansen, Christian Stevns
    Farmer, Adam D.
    Karmisholt, Jesper Scott
    Drewes, Asbjorn M.
    Jakobsen, Poul Erik
    Brock, Birgitte
    Brock, Christina
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2020, 8 (06) : 695 - 704
  • [10] Counter-regulatory hormone responses to hypoglycaemia in people with type 1 diabetes after 4 weeks of treatment with liraglutide adjunct to insulin: a randomized, placebo-controlled, double-blind, crossover trial
    Pieber, T. R.
    Deller, S.
    Korsatko, S.
    Jensen, L.
    Christiansen, E.
    Madsen, J.
    Heller, S. R.
    DIABETES OBESITY & METABOLISM, 2015, 17 (08): : 742 - 750
12345